Loading...

Tactile Systems Technology, Inc.

TCMDNASDAQ
Healthcare
Medical - Devices
$13.23
$0.53(4.17%)

Tactile Systems Technology, Inc. (TCMD) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Tactile Systems Technology, Inc. (TCMD), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
6.76%
6.76%
Operating Income Growth
22.95%
22.95%
Net Income Growth
-40.52%
40.52%
Operating Cash Flow Growth
13.39%
13.39%
Operating Margin
6.30%
6.30%
Gross Margin
72.24%
72.24%
Net Profit Margin
5.06%
5.06%
ROE
7.33%
7.33%
ROIC
8.10%
8.10%

Tactile Systems Technology, Inc. (TCMD) Income Statement & Financial Overview

View the income breakdown for Tactile Systems Technology, Inc. TCMD across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$61.27M$85.58M$73.09M$73.22M
Cost of Revenue$22.69M$21.22M$18.94M$19.75M
Gross Profit$38.58M$64.37M$54.15M$53.47M
Gross Profit Ratio$0.63$0.75$0.74$0.73
R&D Expenses$1.74M$2.04M$2.42M$2.23M
SG&A Expenses$47.51M$49.18M$44.96M$45.39M
Operating Expenses$49.26M$51.22M$47.37M$47.62M
Total Costs & Expenses$71.94M$96.03M$66.31M$67.37M
Interest Income$895000.00$3.38M$0.00$0.00
Interest Expense-$424000.00$1.96M$0.00$0.00
Depreciation & Amortization-$47000.00-$4000.00$1.73M$1.71M
EBITDA-$4.54M$12.52M$8.52M$7.56M
EBITDA Ratio-$0.07$0.15$0.12$0.10
Operating Income-$4.54M$12.52M$6.78M$5.85M
Operating Income Ratio-$0.07$0.15$0.09$0.08
Other Income/Expenses (Net)$471000.00$476000.00$452000.00$225000.00
Income Before Tax-$4.07M$12.99M$7.23M$6.07M
Income Before Tax Ratio-$0.07$0.15$0.10$0.08
Income Tax Expense-$1.10M$3.27M$2.08M$1.78M
Net Income-$2.97M$9.72M$5.16M$4.30M
Net Income Ratio-$0.05$0.11$0.07$0.06
EPS-$0.13$0.40$0.21$0.18
Diluted EPS-$0.13$0.40$0.21$0.18
Weighted Avg Shares Outstanding$23.71M$23.88M$23.99M$23.87M
Weighted Avg Shares Outstanding (Diluted)$23.71M$24.47M$24.25M$24.10M

Over the past four quarters, Tactile Systems Technology, Inc. demonstrated steady revenue growth, increasing from $73.22M in Q2 2024 to $61.27M in Q1 2025. Operating income reached -$4.54M in Q1 2025, maintaining a consistent -7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$4.54M, reflecting operational efficiency. Net income dropped to -$2.97M, with EPS at -$0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;